A Study to Learn About a Vaccine Against E Coli in Healthy Adults
NCT07122986
This study is recruiting at 11 US sites in 5 states, according to its ClinicalTrials.gov record last updated .
Summary
This study evaluates an investigational vaccine designed to protect against Escherichia coli (E coli). The primary objective is to assess the safety and tolerability of E coli vaccines administered intramuscularly to healthy adults.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Healthy Participants
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1
- Ages
- 18 to 64 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Pfizer
- Last updated on ClinicalTrials.gov
- April 30, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 3
- Anaheim Clinical Trials, LLC · Anaheim, CA
- Orange County Research Center · Lake Forest, CA
- Diablo Clinical Research, Inc. · Walnut Creek, CA
Florida · 2
- Miami Eye Institute · Hollywood, FL
- Research Centers of America · Hollywood, FL
New York · 1
- NYU Langone Health · New York, NY
Ohio · 2
- CTI Clinical Research Center · Cincinnati, OH
- Senders Pediatrics · South Euclid, OH
Tennessee · 3
- Alliance for Multispecialty Research, LLC · Knoxville, TN
- Alliance for Multispecialty Research, LLC · Knoxville, TN
- University Eye Specialists, P.C. (Ophthalmologist) · Maryville, TN
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.